Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study
Status:
Unknown status
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is: (1) to examine the effectiveness of reconsolidation blockade as
a treatment for trauma-related disorders, (2) to evaluate the feasibility of implementing
this new treatment on a large scale in a short delay. This clinical trial as been set up in
response to the Paris attacks to increase treatment capacity of the AP-HP (Assistance
Publique des Hopitaux de Paris) hospital network.. Reconsolidation blockade will be compared
to treatment as usual (TAU), on symptoms reduction after 6 weeks of treatment. In order to
measure effectiveness and cost-effectiveness, socioeconomic measures, quality of life and
social functioning outcomes will be measured pre- and post-treatment as well as 3 and 12
months after study enrollment.